Increased capacity anticipated to scale capital production by up to 20X above pre-COVID-19 pandemic levels At maximum capacity, increased production could create up to 350 manufacturing jobs in New ...

EXETER – Vapotherm has ramped up production of its innovative device used in the respiratory treatment of hospitalized COVID-19 patients “20-fold,” according to CEO Joe Army. The Vapotherm technology ...

New Hampshire-based medical device maker Vapotherm Inc. says it is expanding its manufacturing capabilities in Exeter as it focuses on developing and commercializing its Hi-VNI technology products ...

EXETER, N.H., May 20, 2025 /PRNewswire/ -- Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, Effect of ...

Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...

Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single ...

According to Coherent Market Insights, the global nasal cannula market is estimated to account for US$ 10,491.1 mn in terms of value by the end of 2028. A nasal cannula is a medical device that ...

Increased capacity anticipated to scale capital production by up to 20X above pre-COVID-19 pandemic levels At maximum capacity, increased production could create up to 350 manufacturing jobs in New ...

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that ...